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receptor variants in the human population. Nature 358:Thus, we were not able to replicate the ﬁndings of
149–152Grice et al. (1996).
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To the Editor:
Atypical vitelliform macular dystrophy (VMD1; OMIM
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syndrome, by the transmission-disequilibrium test. Am J able (Mintz-Hittner et al. 1984).
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Hebebrand J, No¨then MM, Lehmkuhl G, Poustka F, Schmidt linkage between the VMD1 locus and the soluble gluta-
M, Propping P, Remschmidt H (1993) Tourette’s syndrome mate-pyruvate transaminase (GPT) locus, with a maxi-
and homozygosity for the dopamine D3 receptor gene. Lan- mum two-point LOD score of 4.3 at 5% recombination
cet 341:1483 (Ferrell et al. 1983). At that time, the GPT locus had
Lichter JB, Barr CL, Kennedy JL, Van Tol HHM, Kidd KK,
been mapped tentatively to chromosome 16 (Wijnen andLivak KJ (1993) A hypervariable segment in the human
Meera Khan 1982). Recently, however, we have mappeddopamine receptor D4 (DRD4) gene. Hum Mol Genet 2:
the GPT locus to the long arm of chromosome 8 and767–773
have developed a PCR-RFLP assay for GPT typing (So-No¨then MM, Cichon S, Hemmer S, Hebebrand J, Remschmidt
hocki et al. 1997). All previous GPT typing was by deter-H, Lehmkuhl G, Poustka F, et al (1994a) Human dopamine
D4 receptor gene: frequent occurrence of a null allele and obser- mination of the serologic phenotype only, and, because
vation of homozygosity. Hum Mol Genet 3:2207–2212 there are dramatic quantitative differences between the
No¨then MM, Hebebrand J, Knapp M, Hebebrand K, Camps three common GPT serologic phenotypes (Welch 1972),
A, von Gontard A, Wettke-Scha¨fer R, et al (1994b) Associa- GPT serotyping was difﬁcult. Furthermore, within the
tion analysis of the dopamine D2 receptor gene in Tourette’s last 4 years, several other loci associated with autosomal
syndrome using the haplotype relative risk method. Am J dominant macular degeneration (adMD) have been
Med Genet 54:249–252
mapped to chromosomal sites (table 1). Given the re-Spielman RS, McGinnis RE, Ewens WJ (1993) Transmission
ﬁned localization of the GPT locus and given the addi-test for linkage disequilibrium: the insulin gene region and
tional mapped loci for adMD, it was important to re-insulin-dependent diabetes mellitus (IDDM). Am J Hum
examine the localization of the VMD1 locus in the pre-Genet 52:506–516
viously studied family.Van Tol HHM, Wu CM, Guan H-C, Ohara K, Bunzow JR,
Civelli O, Kennedy J, et al (1992) Multiple dopamine D4 To further characterize the VMD1 locus, we recently
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Table 1
Two-Point LOD Scores between the VMD1 Locus and Candidate Loci
LOD SCORE AT RECOMBINATION FRACTION
CANDIDATE CHROMOSOMAL
DISEASE/GENEa LOCALIZATION MARKER .00 .01 .05 .10 .20 .30 .40 REFERENCE
VMD1 8q24.3b D8S315 038.2 015.5 08.29 04.91 01.9 0.63 0.11 Leach et al. 1996
VMD1 8q24.3b GPT 03.04 01.19 0.50 0.23 0.04 .00 0.01 Ferrell et al. 1983
VMD1 8q24.3b D8S1925 08.90 05.60 03.00 01.50 0.12 .24 .21 Leach et al. 1996
STGD1, FFM 1p21-p13 D1S188 09.75 05.74 02.76 01.47 0.42 0.03 .07 Gerber et al. 1995
RDS 6p21.1-cen D6S271 010.5 06.72 03.46 02.05 0.92 0.48 0.25 Dib et al. 1996
STGD3 6q11-q15 D6S280 03.35 02.64 01.33 0.75 0.27 0.08 0.00 Stone et al. 1994
MCDR1 6q14-q16.2 D6S1717 03.58 02.35 0.92 0.32 .07 .11 .31 Small et al. 1992
CYMD, DCMD 7p21-p15 D7S435 011.5 06.30 03.22 01.90 0.70 0.16 .04 Kremer et al. 1994
VMD2 11q13 D11S480 010.0 07.09 04.04 02.52 01.14 0.51 0.18 Graff et al. 1994
STGD2 13q34 D13S158 017.1 09.12 04.92 02.83 01.07 0.34 0.05 Zhang et al. 1994
RCD2 17p13 D17S796 010.8 07.04 03.29 01.77 0.56 0.14 0.01 Small et al. 1996
CORD2 19q13.3-q13.4 D19S49 09.71 06.28 03.24 01.95 0.86 0.38 0.13 Evans et al. 1994
SFD, TIMP3 22q12.1-q13.2 D22S304 011.7 08.12 04.37 02.75 01.28 0.56 0.17 Wijesuriya et al. 1996;
Weber et al. 1994
a STGD1 Å Stargardt disease; FFM Å fundus ﬂavimaculatus; RDS Å retinal degeneration slow; STGD3 Å Stargardt disease 3; MCDR1
Å dominant North Carolina macular dystrophy; CYMD Å cystoid macular dystrophy; DCMD Å dominant cystoid macular dystrophy; STGD2
Å Stargardt disease 2, macular dystrophy with ﬂecks, type 2; RCD2 Å retinal cone dystrophy 2; CORD2 Å cone-rod retinal dystrophy; SFD
Å fundus dystrophy, pseudoinﬂammatory, of Sorsby; and TIMP3 Å tissue inhibitor of metalloproteinases-3.
b As reported prior to this study.
updated the clinical information for the original family highly unlikely that the VMD1 locus maps to the
known adMD loci.and collected new blood samples. The family was typed
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AGE (Lathrop et al. 1984) (table 1). An autosomal dom- Acknowledgments
inant form of inheritance, with a penetrance of .99, was
This work was supported by grants from the Foundationassumed for both males and females.
Fighting Blindness and the George Gund Foundation (to S.P.D.The new GPT assay corrected the GPT types of three
and L.S.S.), by the Farrish Fund and the MD Anderson Foun-individuals from the original study. With these cor-
dation (to S.P.D.), and by NIH grant EY07142 (to S.P.D.) and
rected GPT types and with the additional blood sam- Institutional National Research Service Award EY07024 (to
ples taken from the VMD1 family for this study, link- M.M.S.). We thank Dr. Susan Blanton, of the University of
age between the VMD1 locus and the GPT locus is no Virginia, Charlottesville, for technical assistance. We also
longer apparent (table 1). Additionally, linkage testing thank the VMD1 family for their enthusiastic cooperation.
between the VMD1 locus and D8S1925 excludes link-
age of the VMD1 locus to the most distal region of
References8q24.3, over a genetic distance of Ç15 cM proximal
to the telomere. Linkage of the VMD1 locus to the Dib C, Faure S, Fizames C, Samson D, Drouot V, Vignal A,
known adMD loci tested also was excluded. There- Millasseau P, et al (1996) A comprehensive genetic map of
fore, it is unlikely that the VMD1 locus in this family the human genome based on 5,264 microsatellites. Nature
380:152–154maps to 8q24.3 as originally reported, and it also is
/ 9a2d$$jy27 07-09-97 14:20:50 ajhga UC-AJHG
241Letters to the Editor
Evans K, Fryer A, Inglehearn C, Duvall-Young J, Whittaker CE (1994) A dominant Stargardt’s macular dystrophy locus
maps to chromosome 13q34. Arch Ophthalmol 112:759–764JL, Gregory CY, Butler R, et al (1994) Genetic linkage of
cone-rod dystrophy to chromosome 19q and evidence for
segregation distortion. Nat Genet 6:210–213 Address for correspondence and reprints: Dr. Stephen P. Daiger, Human Genetics
Center, School of Public Health, The University of Texas Health Science Center,Ferrell RE, Mintz Hittner H, Antoszyk JH (1983) Linkage
P.O. Box 20334, Houston, TX 77225-0334. E-mail: sdaiger@bcm.tmc.eduof atypical vitelliform macular dystrophy (VMD-1) to the
 1997 by The American Society of Human Genetics. All rights reserved.
soluble glutamate pyruvate transaminase (GPT1) locus. Am 0002-9297/97/6101-0034$02.00
J Hum Genet 35:78–84
Gerber S, Rozet J-M, Bonneau D, Souied E, Camuzat A, Duﬁer
J-L, Amalric P, et al (1995) A gene for late-onset fundus
ﬂavimaculatus with macular dystrophy maps to chromo-
some 1p13. Am J Hum Genet 56:396–399
Am. J. Hum. Genet. 61:241–244, 1997Graff C, Forsman K, Larsson C, Nordstrom S, Lind L, Johanson
K, Sandgren O, et al (1994) Fine mapping of Best’s macular
dystrophy localizes the gene in close proximity to but distinct Diagnostic Testing for Prader-Willi and Angelman
from the D11S480/ROM1 loci. Genomics 24:425–434 Syndromes: Response
Kremer H, Pinckers A, Van den Heim B, Deutman AF, Ropers
HH, Mariman ECM (1994) Localization of the gene for To the Editor:
dominant cystoid macular dystrophy on chromosome 7p. The letter by Monaghan et al. (1997) in the January
Hum Mol Genet 3:299–302 1997 issue of the Journal, discussing testing for Prader-
Lathrop GM, Lalouel JM, Julier C, Ott J (1984) Strategies for
Willi (PWS) and Angelman (AS) syndromes, raised sev-multipoint linkage analysis in humans. Proc Natl Acad Sci
eral interesting points. Essentially the issues related toUSA 81:3443–3446
the sequence of diagnostic testing for PWS/AS (cytoge-Leach RJ, Banga SS, Ben-Othame K, Chughtai S, Clarke R,
netics, methylation testing, and FISH), considering theDaiger SP, Kolehmainen J, et al (1996) Report of the Third
pick-up rate of abnormal results and the costs involved.International Workshop on Human Chromosome 8 Map-
Several others have addressed this topic (Chu et al. 1994;ping. Cytogenet Cell Genet 75:71–84
Mintz-Hittner H, Ferrell RE, Borda RP, Justice J Jr (1984) Smith et al. 1995; Young 1995; American Society of
Atypical vitelliform macular dystrophy in a 5-generation Human Genetics/American College of Medical Genetics
family. Br J Ophthalmol 68:199–207 Test and Technology Transfer Committee 1996; Erdel
Small KW, Syrquin M, Mellen L, Gehrs K (1996) Mapping of et al. 1996; Kubota et al. 1996), but Monaghan et al.
autosomal dominant cone degeneration to chromosome (1997) are the ﬁrst to include discussion of the costs of
17p. Am J Ophthalmol 121:13–18 testing. We would like to (a) relate our 12-mo experience
Small KW, Weber JL, Roses A, Lennon F, Vance JM, Pericak- of performing diagnostic tests for a referred group of
Vance MA (1992) North Carolina macular dystrophy is patients suspected to have PWS or AS and (b) review
localized to 6q14-q16.2. Am J Hum Genet Suppl 51:A34
the logistics and costs of multiple testing.Sohocki MM, Sullivan LS, Harrison WR, Sodergen EJ, Elder
Our department of cytogenetics is well established,FFB, Weinstock G, Tanase S, et al (1997) Human glutamate
with a specimen receptionist, an excellent blood labora-pyruvate transaminase (GPT): localization to 8q24.3, cDNA
tory, and staff dedicated to FISH. Our newly institutedand genomic sequences, and polymorphic sites. Genomics
molecular laboratory has one staff scientist who per-40:247–252
forms DNA extractions and the methylation test. A staffStone EM, Nichols BE, Kimura AE, Weingeist TA, Drack A,
cytogeneticist (A.S.) consults with patients/referring cli-Shefﬁeld VC (1994) Clinical features of a Stargardt-like
dominant progressive macular dystrophy with genetic link- nicians, obtains clinical information, and coordinates
age to chromosome 6q. Arch Ophthalmol 112:765–772 the whole process. Within the one department, the
Weber BHF, Vogt G, Pruett RC, Stohr H, Felbor U (1994) whole is well accommodated, with adjacent laboratories
Mutations in the tissue inhibitor of metalloproteinases-3 and ofﬁces. All concerned work closely together.
(TIMP3) in patients with Sorsby’s fundus dystrophy. Nat Cytogenetic analysis on high-resolution chromosomes
Genet 8:352–356 (HRC) had been performed for many years in our labo-
Welch SG (1972) Quantitative differences between the human ratory. FISH for PWS/AS was piloted in 1991 and re-
red cell glutamate-pyruvate transaminase phenotypes. Hum
placed HRC in 1993. We began methylation analysis in
Hered 22:190–197
1995. Our aim was to obtain a result on the index caseWijesuriya SD, Evans K, Jay MR, Davison C, Weber BHF, Bird
from a single blood collection, using a coordinated ap-AC, Bhattacharya SS, et al (1996) Sorsby’s fundus dystrophy
proach. Routine cytogenetics and DNA extractionin the British Isles: demonstration of a striking founder effect
would be performed simultaneously. The suspensionby microsatellite-generated haplotypes. Genome Res 6:92–101
from the cytogenetic harvest would be forwarded to theWijnen LMM, Meera Khan P (1982) Assignment of GPT to
FISH laboratory. Methylation analysis would be per-human chromosome 16. Cytogenet Cell Genet 32:327
Zhang K, Bither PP, Parl R, Donoso LA, Seidman JG, Seidman formed on an aliquot of the extracted DNA. Finally,
/ 9a2d$$jy27 07-09-97 14:20:50 ajhga UC-AJHG
